NeuroDiscovery AI Verified Company

NeuroDiscovery AI is a pioneer in Neurological disorders data research services. Our vision is to create a world where debilitating neurological conditions would be able to be prevented and even reversed. Our goal is to transform patient care by utilizing large amounts of medical data and artificial intelligence. Founded by a team of enthusiastic neurologists, data scientists, and computational biologists, NeuroDiscovery AI arose from a simple yet strong premise that the key to unlocking discoveries in neurology rests in the massive amount of patient data amassed over years of clinical practice. We are at the forefront of neurological research service today, armed with: 

- The largest longitudinal dataset in neuroscience in the world
- Collaborations with more than 550 top neurology specialists in the US 
- An extensive database with multimodal data taken from more than 5 million patients
- State-of-the-art AI technology to extract valuable insights from complicated data

Our Approach: We integrate cutting-edge AI methods, such as: 

• Large language models

• Knowledge graphs

• Topological analyses

We can: 

• Create standards more quickly

• Facilitate more accurate patient matching

• Enhance treatment selection

• Find new biomarkers and novel targets

Come Along with Us to Transform Neurology:

We extend an invitation to everyone involved in this fascinating journey, be it investors, pharmaceutical companies, healthcare providers, or researchers. By working together, we can significantly improve the lives of patients and open up new avenues for neurological care research services.

NeuroDiscovery AI streamlines clinical trial recruitment and real-world evidence generation in neurology by rapidly identifying and delivering qualified participants, often in a fraction of the time required by traditional approaches. Its proprietary NeuroLLM model, leveraging a dataset of over five million patient records and more than 1.5 million active candidates, enables instant access to comprehensive data and supports enrollment within weeks. This accelerated workflow provides sponsors with quick, actionable insights for faster regulatory submissions and reliable study outcomes.